Fundamental Concepts For New Clinical Trialists May 2026

This is the moral compass of clinical trials. is the genuine uncertainty within the medical community about which treatment is better. If we already know for a fact that Treatment A is superior to Treatment B, it is unethical to start a trial. We only experiment when there is a true "honest doubt" to resolve.

What does "success" look like? You must define this before the first patient is enrolled.

Blinding (or masking) prevents the "placebo effect" or observer bias from creeping into the data. The patient doesn't know their treatment. Fundamental Concepts for New Clinical Trialists

Neither the patient nor the researcher knows.As a trialist, your job is to maintain this "seal" throughout the study. Once the blind is broken, the statistical weight of your findings drops significantly. 3. Choosing the Right Endpoints

Moving from a clinical or research background into trial design can feel like learning a new language. While the science drives the study, the ensures the results actually mean something. This is the moral compass of clinical trials

The main question the study is powered to answer (e.g., "Does this drug lower blood pressure?").

Additional data points (e.g., "Does it also improve quality of sleep?"). We only experiment when there is a true

Indicators like biomarkers that predict a clinical benefit, even if they aren't the benefit themselves. 4. The Ethics of Equipoise